Tumor suppressor protein VHL is induced at high cell density and mediates contact inhibition of cell growth (Q58323648)

1

0 references

Syu-ichi Hirai

2

0 references

Satoshi Kawakami

3

0 references

Takeshi Kishida

4

0 references

Naoki Sakai

5

0 references

Shigeki Kaneko

6

0 references

Masahiro Yao

7

0 references

Taro Shuin

8

0 references

Yoshinobu Kubota

9

0 references

Masahiko Hosaka

10

0 references

Shigeo Ohno

https://scigraph.springernature.com/pub.10.1038/sj.onc.1204397

11

0 references

language of work or name

English

0 references

publication date

May 2001

0 references

published in

Oncogene

0 references

volume

20

0 references

page(s)

2727-2736

0 references

issue

22

0 references

exact match

0 references

cites work

Functional interaction of beta-catenin with the transcription factor LEF-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

CUL-2 is required for the G1-to-S-phase transition and mitotic chromosome condensation in Caenorhabditis elegans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

Mutations of the VHL tumour suppressor gene in renal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

Identification of c-MYC as a target of the APC pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

Wnt-1 modulates cell-cell adhesion in mammalian cells by stabilizing beta-catenin binding to the cell adhesion protein cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

Tumour suppression by the human von Hippel-Lindau gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

Identification of the von Hippel-Lindau disease tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

Expression and function of Drosophila cyclin A during embryonic cell cycle progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

Conjugation of the ubiquitin-like protein NEDD8 to cullin-2 is linked to von Hippel-Lindau tumor suppressor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

LINDAU'S DISEASE. REVIEW OF THE LITERATURE AND STUDY OF A LARGE KINDRED.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

Direct Interaction of the β-Domain of VHL Tumor Suppressor Protein with the Regulatory Domain of Atypical PKC Isotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

Exogenous expression of beta-catenin regulates contact inhibition, anchorage-independent growth, anoikis, and radiation-induced cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

Redistribution of the CDK inhibitor p27 between different cyclin.CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

Dermal fibroblast proliferation is improved by β-catenin overexpression and inhibited by E-cadherin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

A rapid procedure for preparing fluorescein-labeled specific antibodies from whole antiserum: its use in analyzing cytoskeletal architecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

The von Hippel-Lindau tumor suppressor gene product promotes, but is not essential for, NEDD8 conjugation to cullin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

Subcellular localization of the von Hippel-Lindau disease gene product is cell cycle-dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

Immunostaining of the von Hippel-Lindau gene product in normal and neoplastic human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

7 January 2021

Cadherin-mediated adhesion is required for normal growth regulation of human gingival epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

7 January 2021

Recombinant adenovirus expressing Von Hippel-Lindau-mediated cell cycle arrest is associated with the induction of cyclin-dependent kinase inhibitor p27Kip1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

7 January 2021

von Hippel-Lindau disease affecting 43 members of a single kindred

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

7 January 2021

Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

7 January 2021

The von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204397

7 January 2021